Kimberly Moran, PhD

New Capabilities

Leads U.S. rare disease commercialization for UCB

Adults with generalized myasthenia gravis (gMG, a disease that weakens voluntary muscles) can now take their daily Zilbrysq dose with a spring-loaded autoinjector instead of a prefilled syringe. The FDA approved the device on October 16. In a study of 100 people, 90% completed a first injection with no training.

Updated Oct 27